SPHinX 株式会社

English

ABOUT US

SPHinX Inc. is a biotech startup from the National Institute for Materials Science (NIMS), founded in 2024. Our core technology is based on smart polymers (stimuli-responsive polymers).
Our mission is to improve the accessibility and quality of diagnostic tests by increasing their accuracy, sensitivity, and specificity. We aim to save people suffering from preventable and treatable diseases, such as infectious diseases, through our smart polymer technologies (Smart X).
We are dedicated to delivering cutting-edge healthcare solutions to patients across not only Asian, American, and European countries but also the Middle East and Africa, ensuring accessibility and affordability for all. We innovate for the sake of patients and their families.

MANAGEMENT TEAM

  • Mitsuhiro EbaraPresident & Chief Executive Officer (CEO)
  • Makoto SasakiChief Operating Officer (COO)
  • Ahmed NabilChief Technology Officer (CTO)

TECHNOLOGY

Our product portfolio encompasses a wide range of diagnosis and screening areas, including infectious diseases such as HCV, HBV, HIV, and more. From centralized laboratories to homes, our products are designed to address critical healthcare needs and improve patient outcomes.
Our core technology, “Smart X” is a preanalytical technology based on smart polymers (stimuli-responsive polymers).
Smart X can purify and enrich biomarkers by simply heating the specimen.
Our results suggest that applying Smart X technology to rapid antigen tests can improve their accuracy to the PCR level.

CONTACT

SPHinX Inc.
2-1-6 Sengen, Tsukuba, Ibaraki, 305-0047